Cefoxitin (Page 5 of 5)

PRINCIPAL DISPLAY PANEL

NDC 0143-9878-01
CEFOXITIN
FOR INJECTION, USP
1 g*/vial
FOR IV USE ONLY
Rx ONLY
* Each vial contains cefoxitin sodium equivalent to 1 g
cefoxitin. The sodium content is 53.8 mg (2.3 mEq).
For the preparation of IV solutions and the
USUAL ADULT DOSAGE: See package insert.
After initial constitution, the solution maintains
satisfactory potency for 6 hours at room temperature
or for 1 week under refrigeration (below 5ºC (41ºF)).
Store dry material between 2º to 25ºC (36º to 77ºF).
Avoid exposure to temperatures above 50ºC (122ºF).
Color changes in powder or solution do not affect
potency.Date/Time _________________ / _________________

cef 1g unit
(click image for full-size original)


NDC 0143-9878-25 Rx ONLY
CEFOXITIN
FOR INJECTION, USP
1 g*/vial
FOR IV USE ONLY 25 x 1 g vials

cef 1g s-p
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 0143-9877-01
CEFOXITIN
FOR INJECTION, USP
2 g*/vial
FOR IV USE ONLY
Rx ONLY
* Each vial contains cefoxitin sodium equivalent to 2 g
cefoxitin. The sodium content is 107.6 mg (4.6 mEq).
For the preparation of IV solutions and the
USUAL ADULT DOSAGE: See package insert.
After initial constitution, the solution maintains
satisfactory potency for 6 hours at room temperature
or for 1 week under refrigeration (below 5ºC (41ºF)).
Store dry material between 2º to 25ºC (36º to 77ºF).
Avoid exposure to temperatures above 50ºC (122ºF).
Color changes in powder or solution do not affect
potency.
Date/Time _________________ / _________________


NDC 0143-9877-25 Rx ONLY
CEFOXITIN
FOR INJECTION, USP
2 g*/vial
FOR IV USE ONLY 25 x 2 g Vials

cef 2g unit
(click image for full-size original)

cef 2g s-p
(click image for full-size original)

SERIALIZATION IMAGE

Layout 1

CEFOXITIN cefoxitin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0143-9878
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFOXITIN SODIUM (CEFOXITIN) CEFOXITIN 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9878-25 25 VIAL in 1 CARTON contains a VIAL (0143-9878-01)
1 NDC:0143-9878-01 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (0143-9878-25)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065238 03/12/2010
CEFOXITIN cefoxitin injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0143-9877
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CEFOXITIN SODIUM (CEFOXITIN) CEFOXITIN 2 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0143-9877-25 25 VIAL in 1 CARTON contains a VIAL (0143-9877-01)
1 NDC:0143-9877-01 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL This package is contained within the CARTON (0143-9877-25)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065238 03/12/2010
Labeler — Hikma Pharmaceuticals USA Inc. (001230762)

Revised: 04/2023 Hikma Pharmaceuticals USA Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.